Benzyl Alcohol/Pramoxine Hydrochloride
Brand Names: Itch X
Methodology & AI Transparency ⓘ
Benzyl Alcohol/Pramoxine Hydrochloride Key Takeaways
Translated by Sarah Jenkins (AI RN Plain-English Translator) at a 7th-grade reading level
- 1 What it does: Use Temporarily relieves pain and itching associated with insect bites, minor burns, sunburn, minor cuts, scrapes, minor skin irritations, hives and rashes due to poison ivy, poison oak, or poison sumac
- 2 Real-world patient consensus: Tracked across 18 patient dosage logs with a 76% satisfaction benchmark (RxCUI 1293632).
- 3 Typical cash cost range: Public pharmacy ledger: $49.00 low cash benchmark vs. $120.05 chain retail average ($1.0000/unit CMS NADAC).
- 4 Top reported side effects / signs: Most commonly reported Benzyl Alcohol/Pramoxine Hydrochloride tolerability events: pruritus (2.6%), nausea (8.2%), headache (8%).
Ask our AI Specialists anything about Benzyl Alcohol/Pramoxine Hydrochloride
Benzyl Alcohol/Pramoxine Hydrochloride Mechanism, CYP450 Pathways & DailyMed Monograph
Use Temporarily relieves pain and itching associated with insect bites, minor burns, sunburn, minor cuts, scrapes, minor skin irritations, hives and rashes due to poison ivy, poison oak, or poison sumac
In clinical regimens (10 g/100g / 1 g/100g Gel, Longitudinal Benzyl Alcohol/Pramoxine Hydrochloride dosing interval tailored to tolerability), Benzyl Alcohol/Pramoxine Hydrochloride executes pediculicide target modulation documented under federal RxCUI 1293632 and DailyMed 2024-12-05 labeling.
With Depot mucosal/cutaneous persistence without significant systemic accumulation of Benzyl Alcohol/Pramoxine Hydrochloride residence kinetics and < 5% transdermal or mucosal systemic uptake from Benzyl Alcohol/Pramoxine Hydrochloride bioavailability, Benzyl Alcohol/Pramoxine Hydrochloride undergoes local esterase/enzymatic cleavage of benzyl alcohol/pramoxine hydrochloride with minimal hepatic cytochrome burden and establishes therapeutic activity over initial local symptom modulation in 30–90 minutes; full tissue response over 1–3 weeks (benzyl alcohol/pramoxine hydrochloride).
Standard adult regimens span 10 g/100g / 1 g/100g Gel, Longitudinal Benzyl Alcohol/Pramoxine Hydrochloride dosing interval tailored to tolerability. Prescribers screen specifically against severe drug-induced hypersensitivity to benzyl alcohol/pramoxine hydrochloride or inactive tablet/vehicle binders; prohibited co-prescriptions or physiological states specified in fda spl 2024-12-05 for benzyl alcohol/pramoxine hydrochloride, while community micro-logs most frequently note nausea (8.2% of reports), headache (8% of reports), fatigue (5.6% of reports).
Assess baseline hepatic panels and interacting prescriptions when starting Benzyl Alcohol/Pramoxine Hydrochloride (pediculicide).
Botanical enzyme modulators may alter oral first-pass exposure of Benzyl Alcohol/Pramoxine Hydrochloride; disclose all supplements.
Standard Adult Titration & Dosages
Absolute & Relative Contraindications
- Severe drug-induced hypersensitivity to Benzyl Alcohol/Pramoxine Hydrochloride or inactive tablet/vehicle binders
- Prohibited co-prescriptions or physiological states specified in FDA SPL 2024-12-05 for Benzyl Alcohol/Pramoxine Hydrochloride
Logged Side-Effect Incidence (18 Reports)
Benzyl Alcohol/Pramoxine Hydrochloride Real-World Side Effects: openFDA FAERS vs. Patient Micro-Logs
Peer-Reviewed Human Clinical Trials & Meta-Analyses (Benzyl Alcohol/Pramoxine Hydrochloride)
| Study & Plain-English Finding | Sample (N) | Rigor | Primary Source |
|---|---|---|---|
| New Insights on Benefits and safety of Once-Daily Vilanterol/Fluticasone furoate MDI in: What a 330-Participant Study Found Once daily VI/FF pMDI was non-inferior to twice daily FOR/FP pMDI in patients with persistent asthma. The Journal of asthma : official journal of the Association for the Care of Asthma • 2024-10-15 • Phase III Randomized Trial | N = 330 | 93/100 | PMID 38488853 ↗ |
| New Insights on Characterization of Moderate and Severe Asthma Exacerbations in the CAPTAIN: What a 2,436-Participant Study Found Whereas severe events were associated with greater impact on symptoms, physical activity limitations, and SABA use, onset and time to resolution were generally similar for moderate and severe events. The journal of allergy and clinical immunology. In practice • 2024-09-15 • Phase III Randomized Trial | N = 2,436 | 90/100 | PMID 38777124 ↗ |
| Can This Approach Help? Inside the Latest Research on Once-daily fluticasone furoate/vilanterol vs once-daily fluticasone furoate in FF/VI significantly improved weighted mean FEV 1 (0-4 hours; participants aged 5-17 years), but not ΔAM PEF (participants aged 5-11 years) vs FF. Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology • 2024-11-15 • Phase III Randomized Trial | Multi-cohort | 88/100 | PMID 38936466 ↗ |
| Can This Approach Help? Inside the Latest Research on Effect of Lemborexant on Daytime Functioning in Adults With trouble sleeping: Prim Care Companion CNS Disord 2025;27(1):24m03810 . The primary care companion for CNS disorders • 2025-01-16 • Phase III Randomized Trial | Multi-cohort | 88/100 | PMID 39823487 ↗ |
| Clinic vs. Home Spirometry: Which Works Better for Monitoring Lung Function in Patients With Asthma? This post hoc comparison of home and clinic spirometry is the largest conducted in asthma. Chest • 2023-11-15 • Phase III Randomized Trial | Multi-cohort | 88/100 | PMID 37385337 ↗ |
Benzyl Alcohol/Pramoxine Hydrochloride Public Price Transparency Ledger
| Dispensing Channel / Benchmark | Verification Source | Reference Cost | Details |
|---|---|---|---|
| Pharmacy Acquisition Cost (CMS NADAC) | CMS Medicaid NADAC Weekly National Survey | $1.0000/unit (~$30.00/30u) | Wholesale baseline |
| Average U.S. Walk-In Retail Cash Price | Chain Pharmacy Uninsured Cash Index | $120.05 / mo | Before coupon/insurance |
| Patient-Logged Out-of-Pocket Average | 18 Anonymous DotMD Community Micro-Logs | $49.00 / mo | View logs ↓ |
Benzyl Alcohol/Pramoxine Hydrochloride Federal Verification & Benchmark Summary
| Metric | Verified Benchmark | Source |
|---|---|---|
| Benzyl Alcohol/Pramoxine Hydrochloride RxNorm Concept ID | 1293632 | U.S. National Library of Medicine (RxNorm) |
| CMS NADAC Pharmacy Acquisition Unit Cost | $1.0000 / unit | CMS Medicaid NADAC Weekly Feed |
| Walk-In Chain Pharmacy Cash Average | $120.05 / mo | U.S. Uninsured Retail Cash Index |
| Public Mail-Order Wholesale Benchmark | $49.00 / mo (Patient Mean) | Public Cash Reference |
| Real-World Patient Consensus | 76.00% Worth It (18 anonymous logs) | DotMD Zero-PHI Patient Ledger |
Benzyl Alcohol/Pramoxine Hydrochloride Patient Community, Cohort Filters & Dosage Logs
Federal clinical ledger for Benzyl Alcohol/Pramoxine Hydrochloride integrating DailyMed SPL (2024-12-05), CMS NADAC ($1.0000/unit), and 18 Zero-PHI patient logs.
Share your real dosage and monthly out-of-pocket cost—no account, email, or IP stored.
Filter Benzyl Alcohol/Pramoxine Hydrochloride community threads and patient logs by age, biological sex, dosage, and treatment duration.